EUVIMED · CrossrefZeitschrift
Acta Pharmaceutica Sinica B
ISSN 2211-3835 · Elsevier BV
Neueste Artikel
MS-DDF: An intelligent mass spectrometry framework tailored for overcoming the in vivo analytical bottleneck in animal-derived medicines
Dual-mode hepatoprotective nanoplatform combines ROS scavenging and FGF21 activation for precision acute liver injury therapy
A novel MST1-targeting kinsenoside derivative K30 attenuates acute kidney injury by restoring mitochondrial homeostasis
Development of 68Ga-labeled macrocyclic peptide for targeting stimulator of interferon genes
Mendelian randomization–inspired targeted polyphenol nanoplatform for synergistic osteoarthritis therapy
Precise unidirection delivery and site-specific release utilizing a nanocapsules-loaded mucoadhesive in situ gel: Targeted eradication of Helicobacter pylori and gastric homeostasis restoration
Orally delivered exosome-like nanoparticles from Tetrastigma hemsleyanum Diels et Gilg remodel the gut–tumor immune axis to activate antitumor immunity
Pathological progression features-guided biphasic drug delivery supramolecular hydrogel for synergistic cartilage protection in osteoarthritis
Biomimetic tumor microenvironment-responsive prodrug amplifies photoimmunotherapy via TLR2 agonist
Targeting RSK2 reverses endocrine resistance in ER-positive breast cancer via inhibiting the c-Myc–ERBB4 signaling pathway
Targeting cancer-associated neutrophils with biomimetic nano-vaccines loaded with mRNA can enhance the efficacy of immunotherapy for hepatocellular carcinoma
Engineered αvβ6-targeting peptide‒BSH conjugates for boron neutron capture therapy of pancreatic ductal adenocarcinoma
Glutaminolysis inhibition boosts cuproptosis to eliminate breast cancer stem cells
A novel peptide–drug conjugate GV-K for anti-colorectal cancer therapy via mitochondrial apoptosis
Aspirin induces glycolytic reprogramming via lysine salicylation of ALDOA
Biphasic dysregulation of non-muscle myosin IIA drives the AKI-to-CKD transition via an ALDH1A1–retinoic acid–HBEGF/EGFR signaling axis in tubular cells
Charting the N-acyl lipid landscape and decoding their immune dialogues
A probiotic–drug cascade system for inflammatory bowel disease via tryptophan metabolism and gut microbiome remodeling
In situ hydrogel nanovaccine based on whole-cell tumor antigen efficiently activates adaptive immunity for the prevention and treatment of ovarian cancer
Coacervate-based materials as emerging vehicles for drug delivery
Discovery and preclinical evaluation of ZLC853 as a potential clinical candidate covalently targeting CDK12/13 kinases
SARS-CoV-2 inhibits EBV-dependent tumor proliferation through PLpro-mediated degradation of EBNA1
Portulaca oleracea L.-derived extracellular vesicle-like particles reprogram intestinal ILCs to alleviate inflammatory bowel disease and colitis-associated colorectal cancer
A peptide-based nano-PROTAC synergistically driving ferroptosis-immunotherapy in triple-negative breast cancer
Intestinal epithelial CSE-derived H2S alleviates food allergy via modulating the IL-25/ILC2 axis
CAR-T in solid tumors: Obstacles and potential strategies
The conformational–condensate code of GRB2: State switching, spatial organization, and therapeutic windows
Concurrent loss of RB1 facilitates EGFR-TKI resistance in EGFR-mutant lung cancer by modulating histone crotonylation
Author correction to “Long-chain acylcarnitine deficiency promotes hepatocarcinogenesis” [Acta Pharm Sin B 15 (2025) 1383-1396]
Identification of flupirtine as a candidate against liver fibrosis in mice: Preserving mitochondria quality by suppressing calpain 1/complex I/mtROS axis via targeting asparagine synthase
EUVIMED